nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A4—Temozolomide—melanoma	0.193	0.285	CbGbCtD
Salmeterol—CYP3A7—Docetaxel—melanoma	0.124	0.183	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.124	0.183	CbGbCtD
Salmeterol—CYP3A4—Vemurafenib—melanoma	0.106	0.156	CbGbCtD
Salmeterol—CYP3A5—Docetaxel—melanoma	0.093	0.138	CbGbCtD
Salmeterol—CYP3A4—Docetaxel—melanoma	0.0363	0.0537	CbGbCtD
Salmeterol—Tenderness—Bleomycin—melanoma	0.00321	0.00991	CcSEcCtD
Salmeterol—Endocrine disorder—Temozolomide—melanoma	0.00285	0.0088	CcSEcCtD
Salmeterol—Viral infection—Temozolomide—melanoma	0.00262	0.00808	CcSEcCtD
Salmeterol—Infestation NOS—Vemurafenib—melanoma	0.00259	0.00798	CcSEcCtD
Salmeterol—Infestation—Vemurafenib—melanoma	0.00259	0.00798	CcSEcCtD
Salmeterol—Neck pain—Carmustine—melanoma	0.00248	0.00764	CcSEcCtD
Salmeterol—Oral candidiasis—Docetaxel—melanoma	0.00248	0.00764	CcSEcCtD
Salmeterol—Supraventricular tachycardia—Docetaxel—melanoma	0.0024	0.0074	CcSEcCtD
Salmeterol—Musculoskeletal pain—Temozolomide—melanoma	0.00239	0.00738	CcSEcCtD
Salmeterol—Candida infection—Carmustine—melanoma	0.00234	0.00721	CcSEcCtD
Salmeterol—Heartburn—Docetaxel—melanoma	0.00229	0.00705	CcSEcCtD
Salmeterol—Connective tissue disorder—Vemurafenib—melanoma	0.00228	0.00704	CcSEcCtD
Salmeterol—Candida infection—Temozolomide—melanoma	0.00226	0.00696	CcSEcCtD
Salmeterol—Injury—Bleomycin—melanoma	0.00221	0.00683	CcSEcCtD
Salmeterol—Throat sore—Docetaxel—melanoma	0.00218	0.00673	CcSEcCtD
Salmeterol—Oropharyngeal discomfort—Docetaxel—melanoma	0.00216	0.00667	CcSEcCtD
Salmeterol—Cardiac disorder—Vemurafenib—melanoma	0.00216	0.00665	CcSEcCtD
Salmeterol—Dermatitis atopic—Docetaxel—melanoma	0.00212	0.00655	CcSEcCtD
Salmeterol—Mediastinal disorder—Vemurafenib—melanoma	0.00209	0.00646	CcSEcCtD
Salmeterol—Malnutrition—Vemurafenib—melanoma	0.00202	0.00624	CcSEcCtD
Salmeterol—Swelling—Carmustine—melanoma	0.00201	0.00621	CcSEcCtD
Salmeterol—Ear pain—Temozolomide—melanoma	0.00201	0.00621	CcSEcCtD
Salmeterol—Back pain—Vemurafenib—melanoma	0.00196	0.00604	CcSEcCtD
Salmeterol—Rhinorrhoea—Docetaxel—melanoma	0.00194	0.00599	CcSEcCtD
Salmeterol—Gastroenteritis—Temozolomide—melanoma	0.00194	0.00597	CcSEcCtD
Salmeterol—Injury—Carmustine—melanoma	0.00193	0.00596	CcSEcCtD
Salmeterol—Nasal congestion—Temozolomide—melanoma	0.00188	0.00581	CcSEcCtD
Salmeterol—Chest discomfort—Docetaxel—melanoma	0.00178	0.00548	CcSEcCtD
Salmeterol—Cough—Vemurafenib—melanoma	0.00177	0.00545	CcSEcCtD
Salmeterol—Bronchospasm—Bleomycin—melanoma	0.00173	0.00534	CcSEcCtD
Salmeterol—Oropharyngeal pain—Docetaxel—melanoma	0.00173	0.00533	CcSEcCtD
Salmeterol—Arthralgia—Vemurafenib—melanoma	0.00172	0.00531	CcSEcCtD
Salmeterol—Myalgia—Vemurafenib—melanoma	0.00172	0.00531	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00171	0.00528	CcSEcCtD
Salmeterol—Anaphylactic shock—Vemurafenib—melanoma	0.00165	0.00509	CcSEcCtD
Salmeterol—Bone pain—Docetaxel—melanoma	0.00164	0.00506	CcSEcCtD
Salmeterol—Infection—Vemurafenib—melanoma	0.00164	0.00506	CcSEcCtD
Salmeterol—Inflammation—Docetaxel—melanoma	0.00162	0.005	CcSEcCtD
Salmeterol—Nervous system disorder—Vemurafenib—melanoma	0.00162	0.00499	CcSEcCtD
Salmeterol—Skin disorder—Vemurafenib—melanoma	0.0016	0.00495	CcSEcCtD
Salmeterol—Pneumonia—Bleomycin—melanoma	0.00158	0.00487	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0015	0.00464	CcSEcCtD
Salmeterol—Candida infection—Docetaxel—melanoma	0.0015	0.00463	CcSEcCtD
Salmeterol—Pneumonia—Dactinomycin—melanoma	0.00147	0.00454	CcSEcCtD
Salmeterol—Bronchitis—Temozolomide—melanoma	0.00143	0.0044	CcSEcCtD
Salmeterol—Fatigue—Vemurafenib—melanoma	0.00142	0.00439	CcSEcCtD
Salmeterol—Constipation—Vemurafenib—melanoma	0.00141	0.00435	CcSEcCtD
Salmeterol—Hyperglycaemia—Carmustine—melanoma	0.00139	0.00427	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Temozolomide—melanoma	0.00138	0.00425	CcSEcCtD
Salmeterol—Pneumonia—Carmustine—melanoma	0.00138	0.00425	CcSEcCtD
Salmeterol—Hyperglycaemia—Temozolomide—melanoma	0.00134	0.00413	CcSEcCtD
Salmeterol—Urinary tract infection—Carmustine—melanoma	0.00133	0.0041	CcSEcCtD
Salmeterol—Pneumonia—Temozolomide—melanoma	0.00133	0.0041	CcSEcCtD
Salmeterol—Infestation NOS—Temozolomide—melanoma	0.00132	0.00408	CcSEcCtD
Salmeterol—Infestation—Temozolomide—melanoma	0.00132	0.00408	CcSEcCtD
Salmeterol—Body temperature increased—Vemurafenib—melanoma	0.00131	0.00403	CcSEcCtD
Salmeterol—Pharyngitis—Dactinomycin—melanoma	0.0013	0.00402	CcSEcCtD
Salmeterol—Swelling—Docetaxel—melanoma	0.00129	0.00399	CcSEcCtD
Salmeterol—Urinary tract infection—Temozolomide—melanoma	0.00129	0.00397	CcSEcCtD
Salmeterol—Sinusitis—Temozolomide—melanoma	0.00124	0.00383	CcSEcCtD
Salmeterol—Hypersensitivity—Vemurafenib—melanoma	0.00122	0.00375	CcSEcCtD
Salmeterol—Connective tissue disorder—Carmustine—melanoma	0.00121	0.00373	CcSEcCtD
Salmeterol—Atrial fibrillation—Docetaxel—melanoma	0.0012	0.00372	CcSEcCtD
Salmeterol—Asthenia—Vemurafenib—melanoma	0.00118	0.00365	CcSEcCtD
Salmeterol—Pharyngitis—Temozolomide—melanoma	0.00118	0.00364	CcSEcCtD
Salmeterol—Connective tissue disorder—Temozolomide—melanoma	0.00117	0.0036	CcSEcCtD
Salmeterol—Pain in extremity—Docetaxel—melanoma	0.00114	0.00352	CcSEcCtD
Salmeterol—Ill-defined disorder—Bleomycin—melanoma	0.00114	0.00351	CcSEcCtD
Salmeterol—Diarrhoea—Vemurafenib—melanoma	0.00113	0.00348	CcSEcCtD
Salmeterol—Migraine—Docetaxel—melanoma	0.00112	0.00347	CcSEcCtD
Salmeterol—Malaise—Bleomycin—melanoma	0.00111	0.00341	CcSEcCtD
Salmeterol—Cardiac disorder—Temozolomide—melanoma	0.0011	0.0034	CcSEcCtD
Salmeterol—Arrhythmia—Carmustine—melanoma	0.0011	0.00339	CcSEcCtD
Salmeterol—Dizziness—Vemurafenib—melanoma	0.00109	0.00337	CcSEcCtD
Salmeterol—Mental disorder—Carmustine—melanoma	0.00108	0.00332	CcSEcCtD
Salmeterol—Immune system disorder—Temozolomide—melanoma	0.00107	0.00331	CcSEcCtD
Salmeterol—Mediastinal disorder—Temozolomide—melanoma	0.00107	0.0033	CcSEcCtD
Salmeterol—Malnutrition—Carmustine—melanoma	0.00107	0.0033	CcSEcCtD
Salmeterol—Cough—Bleomycin—melanoma	0.00107	0.0033	CcSEcCtD
Salmeterol—Ill-defined disorder—Dactinomycin—melanoma	0.00106	0.00327	CcSEcCtD
Salmeterol—Vomiting—Vemurafenib—melanoma	0.00105	0.00324	CcSEcCtD
Salmeterol—Chest pain—Bleomycin—melanoma	0.00104	0.00322	CcSEcCtD
Salmeterol—Myalgia—Bleomycin—melanoma	0.00104	0.00322	CcSEcCtD
Salmeterol—Abdominal pain upper—Docetaxel—melanoma	0.00104	0.00322	CcSEcCtD
Salmeterol—Rash—Vemurafenib—melanoma	0.00104	0.00321	CcSEcCtD
Salmeterol—Mental disorder—Temozolomide—melanoma	0.00104	0.00321	CcSEcCtD
Salmeterol—Dermatitis—Vemurafenib—melanoma	0.00104	0.00321	CcSEcCtD
Salmeterol—Back pain—Carmustine—melanoma	0.00103	0.00319	CcSEcCtD
Salmeterol—Headache—Vemurafenib—melanoma	0.00103	0.00319	CcSEcCtD
Salmeterol—Malnutrition—Temozolomide—melanoma	0.00103	0.00319	CcSEcCtD
Salmeterol—Discomfort—Bleomycin—melanoma	0.00103	0.00318	CcSEcCtD
Salmeterol—Malaise—Dactinomycin—melanoma	0.00103	0.00318	CcSEcCtD
Salmeterol—Cramp muscle—Docetaxel—melanoma	0.00103	0.00317	CcSEcCtD
Salmeterol—Nasopharyngitis—Docetaxel—melanoma	0.00102	0.00315	CcSEcCtD
Salmeterol—Tremor—Carmustine—melanoma	0.001	0.00309	CcSEcCtD
Salmeterol—Anaphylactic shock—Bleomycin—melanoma	0.001	0.00309	CcSEcCtD
Salmeterol—Oedema—Bleomycin—melanoma	0.001	0.00309	CcSEcCtD
Salmeterol—Back pain—Temozolomide—melanoma	0.001	0.00308	CcSEcCtD
Salmeterol—Infection—Bleomycin—melanoma	0.000994	0.00307	CcSEcCtD
Salmeterol—Agitation—Carmustine—melanoma	0.000983	0.00303	CcSEcCtD
Salmeterol—Nausea—Vemurafenib—melanoma	0.000981	0.00302	CcSEcCtD
Salmeterol—Myalgia—Dactinomycin—melanoma	0.000973	0.003	CcSEcCtD
Salmeterol—Bronchospasm—Docetaxel—melanoma	0.000971	0.00299	CcSEcCtD
Salmeterol—Tremor—Temozolomide—melanoma	0.000969	0.00299	CcSEcCtD
Salmeterol—Discomfort—Dactinomycin—melanoma	0.000962	0.00297	CcSEcCtD
Salmeterol—Ill-defined disorder—Temozolomide—melanoma	0.000959	0.00296	CcSEcCtD
Salmeterol—Agitation—Temozolomide—melanoma	0.00095	0.00293	CcSEcCtD
Salmeterol—Angioedema—Temozolomide—melanoma	0.000945	0.00291	CcSEcCtD
Salmeterol—Oedema—Dactinomycin—melanoma	0.000933	0.00288	CcSEcCtD
Salmeterol—Malaise—Temozolomide—melanoma	0.000932	0.00288	CcSEcCtD
Salmeterol—Infection—Dactinomycin—melanoma	0.000927	0.00286	CcSEcCtD
Salmeterol—Hypertension—Carmustine—melanoma	0.000924	0.00285	CcSEcCtD
Salmeterol—Palpitations—Temozolomide—melanoma	0.000914	0.00282	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000911	0.00281	CcSEcCtD
Salmeterol—Chest pain—Carmustine—melanoma	0.000911	0.00281	CcSEcCtD
Salmeterol—Myalgia—Carmustine—melanoma	0.000911	0.00281	CcSEcCtD
Salmeterol—Anxiety—Carmustine—melanoma	0.000908	0.0028	CcSEcCtD
Salmeterol—Cough—Temozolomide—melanoma	0.000902	0.00278	CcSEcCtD
Salmeterol—Paraesthesia—Bleomycin—melanoma	0.000898	0.00277	CcSEcCtD
Salmeterol—Hypertension—Temozolomide—melanoma	0.000893	0.00275	CcSEcCtD
Salmeterol—Dyspnoea—Bleomycin—melanoma	0.000892	0.00275	CcSEcCtD
Salmeterol—Pneumonia—Docetaxel—melanoma	0.000885	0.00273	CcSEcCtD
Salmeterol—Myalgia—Temozolomide—melanoma	0.00088	0.00271	CcSEcCtD
Salmeterol—Arthralgia—Temozolomide—melanoma	0.00088	0.00271	CcSEcCtD
Salmeterol—Infestation NOS—Docetaxel—melanoma	0.00088	0.00271	CcSEcCtD
Salmeterol—Infestation—Docetaxel—melanoma	0.00088	0.00271	CcSEcCtD
Salmeterol—Anxiety—Temozolomide—melanoma	0.000877	0.00271	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000874	0.0027	CcSEcCtD
Salmeterol—Oedema—Carmustine—melanoma	0.000873	0.00269	CcSEcCtD
Salmeterol—Discomfort—Temozolomide—melanoma	0.00087	0.00268	CcSEcCtD
Salmeterol—Infection—Carmustine—melanoma	0.000867	0.00268	CcSEcCtD
Salmeterol—Dry mouth—Temozolomide—melanoma	0.000861	0.00266	CcSEcCtD
Salmeterol—Pain—Bleomycin—melanoma	0.000855	0.00264	CcSEcCtD
Salmeterol—Conjunctivitis—Docetaxel—melanoma	0.000855	0.00264	CcSEcCtD
Salmeterol—Tachycardia—Carmustine—melanoma	0.000852	0.00263	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00085	0.00262	CcSEcCtD
Salmeterol—Oedema—Temozolomide—melanoma	0.000844	0.0026	CcSEcCtD
Salmeterol—Anaphylactic shock—Temozolomide—melanoma	0.000844	0.0026	CcSEcCtD
Salmeterol—Infection—Temozolomide—melanoma	0.000838	0.00259	CcSEcCtD
Salmeterol—Epistaxis—Docetaxel—melanoma	0.00083	0.00256	CcSEcCtD
Salmeterol—Nervous system disorder—Temozolomide—melanoma	0.000827	0.00255	CcSEcCtD
Salmeterol—Feeling abnormal—Bleomycin—melanoma	0.000824	0.00254	CcSEcCtD
Salmeterol—Skin disorder—Temozolomide—melanoma	0.00082	0.00253	CcSEcCtD
Salmeterol—Fatigue—Dactinomycin—melanoma	0.000804	0.00248	CcSEcCtD
Salmeterol—Pain—Dactinomycin—melanoma	0.000798	0.00246	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Carmustine—melanoma	0.000796	0.00245	CcSEcCtD
Salmeterol—Urticaria—Bleomycin—melanoma	0.000795	0.00245	CcSEcCtD
Salmeterol—Rhinitis—Docetaxel—melanoma	0.000792	0.00244	CcSEcCtD
Salmeterol—Body temperature increased—Bleomycin—melanoma	0.000791	0.00244	CcSEcCtD
Salmeterol—Insomnia—Carmustine—melanoma	0.00079	0.00244	CcSEcCtD
Salmeterol—Paraesthesia—Carmustine—melanoma	0.000784	0.00242	CcSEcCtD
Salmeterol—Pharyngitis—Docetaxel—melanoma	0.000784	0.00242	CcSEcCtD
Salmeterol—Dyspnoea—Carmustine—melanoma	0.000778	0.0024	CcSEcCtD
Salmeterol—Connective tissue disorder—Docetaxel—melanoma	0.000776	0.00239	CcSEcCtD
Salmeterol—Feeling abnormal—Dactinomycin—melanoma	0.000769	0.00237	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000769	0.00237	CcSEcCtD
Salmeterol—Insomnia—Temozolomide—melanoma	0.000763	0.00235	CcSEcCtD
Salmeterol—Gastrointestinal pain—Dactinomycin—melanoma	0.000763	0.00235	CcSEcCtD
Salmeterol—Paraesthesia—Temozolomide—melanoma	0.000758	0.00234	CcSEcCtD
Salmeterol—Dyspnoea—Temozolomide—melanoma	0.000752	0.00232	CcSEcCtD
Salmeterol—Constipation—Carmustine—melanoma	0.000747	0.0023	CcSEcCtD
Salmeterol—Pain—Carmustine—melanoma	0.000747	0.0023	CcSEcCtD
Salmeterol—Dyspepsia—Temozolomide—melanoma	0.000743	0.00229	CcSEcCtD
Salmeterol—Abdominal pain—Dactinomycin—melanoma	0.000737	0.00227	CcSEcCtD
Salmeterol—Body temperature increased—Dactinomycin—melanoma	0.000737	0.00227	CcSEcCtD
Salmeterol—Hypersensitivity—Bleomycin—melanoma	0.000737	0.00227	CcSEcCtD
Salmeterol—Cardiac disorder—Docetaxel—melanoma	0.000733	0.00226	CcSEcCtD
Salmeterol—Fatigue—Temozolomide—melanoma	0.000727	0.00224	CcSEcCtD
Salmeterol—Constipation—Temozolomide—melanoma	0.000722	0.00223	CcSEcCtD
Salmeterol—Pain—Temozolomide—melanoma	0.000722	0.00223	CcSEcCtD
Salmeterol—Feeling abnormal—Carmustine—melanoma	0.00072	0.00222	CcSEcCtD
Salmeterol—Asthenia—Bleomycin—melanoma	0.000718	0.00221	CcSEcCtD
Salmeterol—Gastrointestinal pain—Carmustine—melanoma	0.000714	0.0022	CcSEcCtD
Salmeterol—Immune system disorder—Docetaxel—melanoma	0.000713	0.0022	CcSEcCtD
Salmeterol—Mediastinal disorder—Docetaxel—melanoma	0.000712	0.0022	CcSEcCtD
Salmeterol—Arrhythmia—Docetaxel—melanoma	0.000706	0.00218	CcSEcCtD
Salmeterol—Feeling abnormal—Temozolomide—melanoma	0.000695	0.00214	CcSEcCtD
Salmeterol—Mental disorder—Docetaxel—melanoma	0.000692	0.00213	CcSEcCtD
Salmeterol—Abdominal pain—Carmustine—melanoma	0.00069	0.00213	CcSEcCtD
Salmeterol—Body temperature increased—Carmustine—melanoma	0.00069	0.00213	CcSEcCtD
Salmeterol—Gastrointestinal pain—Temozolomide—melanoma	0.00069	0.00213	CcSEcCtD
Salmeterol—Malnutrition—Docetaxel—melanoma	0.000688	0.00212	CcSEcCtD
Salmeterol—Hypersensitivity—Dactinomycin—melanoma	0.000687	0.00212	CcSEcCtD
Salmeterol—Urticaria—Temozolomide—melanoma	0.00067	0.00207	CcSEcCtD
Salmeterol—Asthenia—Dactinomycin—melanoma	0.000669	0.00206	CcSEcCtD
Salmeterol—Body temperature increased—Temozolomide—melanoma	0.000667	0.00206	CcSEcCtD
Salmeterol—Abdominal pain—Temozolomide—melanoma	0.000667	0.00206	CcSEcCtD
Salmeterol—Back pain—Docetaxel—melanoma	0.000665	0.00205	CcSEcCtD
Salmeterol—Muscle spasms—Docetaxel—melanoma	0.000661	0.00204	CcSEcCtD
Salmeterol—Hypersensitivity—Carmustine—melanoma	0.000643	0.00198	CcSEcCtD
Salmeterol—Diarrhoea—Dactinomycin—melanoma	0.000638	0.00197	CcSEcCtD
Salmeterol—Vomiting—Bleomycin—melanoma	0.000636	0.00196	CcSEcCtD
Salmeterol—Rash—Bleomycin—melanoma	0.000631	0.00195	CcSEcCtD
Salmeterol—Dermatitis—Bleomycin—melanoma	0.00063	0.00194	CcSEcCtD
Salmeterol—Asthenia—Carmustine—melanoma	0.000626	0.00193	CcSEcCtD
Salmeterol—Hypersensitivity—Temozolomide—melanoma	0.000622	0.00192	CcSEcCtD
Salmeterol—Palpitations—Docetaxel—melanoma	0.000608	0.00187	CcSEcCtD
Salmeterol—Asthenia—Temozolomide—melanoma	0.000605	0.00187	CcSEcCtD
Salmeterol—Cough—Docetaxel—melanoma	0.0006	0.00185	CcSEcCtD
Salmeterol—Diarrhoea—Carmustine—melanoma	0.000597	0.00184	CcSEcCtD
Salmeterol—Nausea—Bleomycin—melanoma	0.000594	0.00183	CcSEcCtD
Salmeterol—Hypertension—Docetaxel—melanoma	0.000594	0.00183	CcSEcCtD
Salmeterol—Vomiting—Dactinomycin—melanoma	0.000593	0.00183	CcSEcCtD
Salmeterol—Rash—Dactinomycin—melanoma	0.000588	0.00181	CcSEcCtD
Salmeterol—Arthralgia—Docetaxel—melanoma	0.000585	0.00181	CcSEcCtD
Salmeterol—Myalgia—Docetaxel—melanoma	0.000585	0.00181	CcSEcCtD
Salmeterol—Chest pain—Docetaxel—melanoma	0.000585	0.00181	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000581	0.00179	CcSEcCtD
Salmeterol—Dizziness—Carmustine—melanoma	0.000577	0.00178	CcSEcCtD
Salmeterol—Diarrhoea—Temozolomide—melanoma	0.000577	0.00178	CcSEcCtD
Salmeterol—Dry mouth—Docetaxel—melanoma	0.000572	0.00177	CcSEcCtD
Salmeterol—Oedema—Docetaxel—melanoma	0.000561	0.00173	CcSEcCtD
Salmeterol—Anaphylactic shock—Docetaxel—melanoma	0.000561	0.00173	CcSEcCtD
Salmeterol—Dizziness—Temozolomide—melanoma	0.000558	0.00172	CcSEcCtD
Salmeterol—Infection—Docetaxel—melanoma	0.000557	0.00172	CcSEcCtD
Salmeterol—Vomiting—Carmustine—melanoma	0.000555	0.00171	CcSEcCtD
Salmeterol—Nausea—Dactinomycin—melanoma	0.000554	0.00171	CcSEcCtD
Salmeterol—Rash—Carmustine—melanoma	0.000551	0.0017	CcSEcCtD
Salmeterol—Nervous system disorder—Docetaxel—melanoma	0.00055	0.0017	CcSEcCtD
Salmeterol—Dermatitis—Carmustine—melanoma	0.00055	0.0017	CcSEcCtD
Salmeterol—Tachycardia—Docetaxel—melanoma	0.000548	0.00169	CcSEcCtD
Salmeterol—Headache—Carmustine—melanoma	0.000547	0.00169	CcSEcCtD
Salmeterol—Skin disorder—Docetaxel—melanoma	0.000545	0.00168	CcSEcCtD
Salmeterol—Vomiting—Temozolomide—melanoma	0.000536	0.00165	CcSEcCtD
Salmeterol—Rash—Temozolomide—melanoma	0.000532	0.00164	CcSEcCtD
Salmeterol—Dermatitis—Temozolomide—melanoma	0.000532	0.00164	CcSEcCtD
Salmeterol—Headache—Temozolomide—melanoma	0.000529	0.00163	CcSEcCtD
Salmeterol—Nausea—Carmustine—melanoma	0.000519	0.0016	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000511	0.00158	CcSEcCtD
Salmeterol—Insomnia—Docetaxel—melanoma	0.000508	0.00157	CcSEcCtD
Salmeterol—Paraesthesia—Docetaxel—melanoma	0.000504	0.00155	CcSEcCtD
Salmeterol—Nausea—Temozolomide—melanoma	0.000501	0.00155	CcSEcCtD
Salmeterol—Dyspnoea—Docetaxel—melanoma	0.0005	0.00154	CcSEcCtD
Salmeterol—Dyspepsia—Docetaxel—melanoma	0.000494	0.00152	CcSEcCtD
Salmeterol—Fatigue—Docetaxel—melanoma	0.000484	0.00149	CcSEcCtD
Salmeterol—Constipation—Docetaxel—melanoma	0.00048	0.00148	CcSEcCtD
Salmeterol—Pain—Docetaxel—melanoma	0.00048	0.00148	CcSEcCtD
Salmeterol—Feeling abnormal—Docetaxel—melanoma	0.000462	0.00143	CcSEcCtD
Salmeterol—Gastrointestinal pain—Docetaxel—melanoma	0.000459	0.00142	CcSEcCtD
Salmeterol—Abdominal pain—Docetaxel—melanoma	0.000444	0.00137	CcSEcCtD
Salmeterol—Body temperature increased—Docetaxel—melanoma	0.000444	0.00137	CcSEcCtD
Salmeterol—Hypersensitivity—Docetaxel—melanoma	0.000413	0.00128	CcSEcCtD
Salmeterol—Asthenia—Docetaxel—melanoma	0.000403	0.00124	CcSEcCtD
Salmeterol—Diarrhoea—Docetaxel—melanoma	0.000384	0.00118	CcSEcCtD
Salmeterol—Dizziness—Docetaxel—melanoma	0.000371	0.00114	CcSEcCtD
Salmeterol—Vomiting—Docetaxel—melanoma	0.000357	0.0011	CcSEcCtD
Salmeterol—Rash—Docetaxel—melanoma	0.000354	0.00109	CcSEcCtD
Salmeterol—Dermatitis—Docetaxel—melanoma	0.000353	0.00109	CcSEcCtD
Salmeterol—Headache—Docetaxel—melanoma	0.000352	0.00108	CcSEcCtD
Salmeterol—Nausea—Docetaxel—melanoma	0.000333	0.00103	CcSEcCtD
